CHOP’s Congenital Hyperinsulinism Center Celebrates 20 Years and 500 Surgeries
Published on
The center offers evaluation, diagnosis, treatment, and follow-up care for children with this life-threatening condition.
Congenital Hyperinsulinism News and Updates
11 - 20 of 27
Pioneers in Hyperinsulinism: Yesterday, Today and Tomorrow
Published on
CHOP’s groundbreaking expertise in treating children with congenital hyperinsulinism (HI) began more than 50 years ago and draws patients from all over the world.
Two Generations. Two Buildings. Always Expert Care: Parkes Family HI Story
Published on
Two generations of the Parkes family have come to Children’s Hospital of Philadelphia for treatment for hyperinsulinism (HI). They’ve seen and experienced breakthroughs in HI care firsthand.
Trailblazing HI Treatments Begin at CHOP
Published on
Leaders of the HI Center at CHOP remember two decades of advancements in care for children with HI.
Missing or Medicated Pancreas Means Missing Key Enzymes
Published on
Children with congenital hyperinsulinism (HI) may be at risk for exocrine pancreatic insufficiency, which affects the ability of the pancreas to function properly.
The Ups and Downs of Living with HI
Published on
Patients share their experiences of growing up with HI during the 2016 Congenital Hyperinsulinism Family Conference in Philadelphia.
Dr. Stanley’s Pioneering Career Recognized
Published on
Charles A. Stanley, MD, received the Judson J. Van Wyk Prize, the most prestigious award given by the Pediatric Endocrine Society.
Complex Biology of Hyperinsulinism May Offer Clues to Better Treatment
Published on
Studying cells from children born with hyperinsulinism, CHOP experts discover events at the cellular level that may lead to new treatments for this rare disease.
HI Center Names New Director of Inpatient Care
Published on
CHOP's Congenital Hyperinsulism Center taps David R. Langdon, MD, to be director of inpatient service as former director Andrew Palladino, MD, moves to HI outpatient clinic.
Pilot Study: Investigational Drug Shows Promise for Diffuse HI Patients
Published on
CHOP has found that an investigational drug could point to the first potential medical treatment for children with a type of HI.